_256_384.jpg)
Medical Device | November 25, 2024
Sourav Ganguly launches Beurer India's GL 22 Blood Glucose Monitor
The GL 22 Blood Glucose Monitor combines German precision with advanced technology designed to meet local needs
The GL 22 Blood Glucose Monitor combines German precision with advanced technology designed to meet local needs
EU approval makes Novo Nordisk’s oral semaglutide the first and only oral GLP-1 RA to reduce cardiovascular death, heart attack and stroke
The built-in AI-trained algorithms will empower users to proactively intervene when their glucose levels require attention and before a complication can even occur
This acquisition enables MTD to open new, strategic markets
Carmot Therapeutics’s R&D portfolio of clinical stage incretins has great potential to treat obesity, diabetes and potentially other diseases
Senvelgo is the first liquid once-daily, orally administered prescription medication to improve glycemic control in cats with diabetes mellitus
The two generic drugs have been launched under the brand names Jankey & Sitenali.
In the trial, there was no statistical difference in estimated hypoglycaemia rates, and no severe hypoglycaemia events were observed for people treated with insulin icodec
Key findings underscore the need for better control of glycemia, blood pressure and lipid parameters to prevent diabetes-related complications
Celerity Pharmaceuticals uses Biocon Biologics’ insulin drug substance to develop the product
Subscribe To Our Newsletter & Stay Updated
